MedAI Verdict

AI Pathology · 31 tools

Editorial illustration: a histology slide on a microscope stage, with cellular structures annotated in blue.

Deciphex

Deciphex logo
7/ 100

Evidence & Documentation Score

This legacy score reflects documented evidence, integrations, transparency, and market signals. It does not measure overall product performance. A new product-focused rating system is in development. How it is computed

reviewed November 2, 2026

Vendor
Deciphex, IE
Pricing
No public price.
EHR
Not stated
Compliance
ISO 27001

Bottom line. Deciphex sells remote pathologist reporting and preclinical digital pathology through two described brands, Diagnexia in the UK and Patholytix, with CipherX as the group's AI engine, used for preclinical models. No clinician-facing AI product is identified, and the homepage and About page carry no CE-IVD, IVDR, FDA or research-use-only marking. A department that wants outsourced primary reports or secondary consults… Read the full bottom line

Performance profile

  • Regulatory and compliance0 / 28
  • Clinical integration0 / 6.6
  • Evidence strength0 / 28.8
  • Vendor and market3 / 12
  • Sentiment and transparency2.5 / 5

Performance profile

  • Regulatory and compliance0 / 28
  • Clinical integration0 / 6.6
  • Evidence strength0 / 28.8
  • Vendor and market3 / 12
  • Sentiment and transparency2.5 / 5
On this page

All 8 dimensions

Regulatory and compliance

  • FDA clearance0 / 18

    No FDA clearance listed

  • HIPAA / SOC2 / BAA0 / 10

    No public HIPAA/SOC2/BAA attestation

Clinical integration

  • EHR integrations (count)0 / 4.2

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.4

    None of the top-3 EHRs covered

Evidence strength

  • Peer-reviewed papers0 / 21

    No peer-reviewed paper evaluating the product

  • RCT / meta-analysis / systematic review0 / 7.8

    No RCT, meta-analysis, or systematic review evaluating the product

Vendor and market

  • Funding & adoption signal3 / 12

    Seed-stage or unfunded

Sentiment and transparency

  • Pricing transparency2.5 / 5

    Pricing on request, no public amounts

Computed November 6, 2026 by our public rubric. How it’s computed

What it costs

From
No public price.
Price points
1
Verified
November 2, 2026
Source
Vendor pricing page

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price.

Source: vendor pricing page. Last checked November 2, 2026.

Compliance

Attested
ISO 27001
EHR integrations
Not stated
FDA
Not stated

Carries ISO 27001 per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.

Vendor stability

Company
Deciphex
Headquarters
IE
Founded
Not stated

Vendor sitewww.deciphex.com (opens in new tab)

Evidence record

RecordWhat we found
FDA decisions

No FDA decision cited in our research as of November 6, 2026.

Verification
  • Score computed November 6, 2026, method 1.2.1
  • Review written November 2, 2026
Cite this record

MedAI Verdict, Deciphex record, https://medaiverdict.com/tools/deciphex, version November 2, 2026

Change historyView every change to this record

Bottom line

Deciphex sells remote pathologist reporting and preclinical digital pathology through two described brands, Diagnexia in the UK and Patholytix, with CipherX as the group's AI engine, used for preclinical models. No clinician-facing AI product is identified, and the homepage and About page carry no CE-IVD, IVDR, FDA or research-use-only marking. A department that wants outsourced primary reports or secondary consults is the buyer Diagnexia addresses, and a pharma team that wants GLP digital pathology is Patholytix's. A lab hoping to license regulated diagnostic AI has nothing of that kind described.

Remote pathologist reporting service for hospitals and labs, with AI tools used in preclinical pathology for pharma.

No public price.

What do Diagnexia and Patholytix sell?

Diagnexia calls itself a global digital pathology department, an on-call network of expert subspecialty pathologists, offering primary reports and secondary consults. Patholytix offers "faster, more thorough testing of 100s of drug compounds with GLP-compliant digital pathology", and Deciphex claims it speeds up drug development in 9 of 10 top pharma firms.

The homepage lists Charles River pre-trained models and a collaboration with Novartis on a foundation model. Investors named on the About page include Molten Ventures, Seroba Life Sciences, Charles River and Novartis.

What does Diagnexia promise?

Diagnexia states a turnaround of three to five days for primary diagnostic reports and seven to ten days for secondary consults. Export into a lab information system depends on a technical project and minimum case volumes. The vendor claims it reduces pathology wait times from two months to two days and integrates directly with NHS systems.

Diagnexia states UKAS accreditation to ISO 15189:2022 for the Oxford histology laboratory, CQC registration for its Oxford and Exeter sites, and ISO 27001.

Does Deciphex sell regulated AI?

CipherX is described as an AI engine for pathology questions, and Deciphex calls itself its first and largest user. Its documented use is pre-trained models for preclinical studies, and no clinical AI claim accompanies it. No published evaluation of a Deciphex product is verified.

How does the framework agreement affect price?

Diagnexia is a supplier on a National Framework Agreement for Teleradiology, Telepathology and Telemedicine Services. The vendor promises transparent pricing and reduced procurement times, and the framework prices are unpublished.

The verdict

Diagnexia is the product to weigh for a department that wants to hand off primary reports or consults, with a stated UKAS accreditation and stated turnaround behind it. Patholytix is the one for a pharma team running GLP studies. A buyer seeking cleared diagnostic AI software has no Deciphex product to evaluate.

Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

Link to this review

Deciphex, reviewed on MedAI Verdict

Vendors may place this badge on their own site. It links to this review with a tracking parameter and has no effect on the score.

<a href="https://medaiverdict.com/tools/deciphex?utm_source=vendor_badge&utm_medium=badge&utm_campaign=deciphex"><img src="https://medaiverdict.com/badges/reviewed-on-medaiverdict.png" srcset="https://medaiverdict.com/badges/reviewed-on-medaiverdict@2x.png 2x" alt="Deciphex, reviewed on MedAI Verdict" width="200" height="56"></a>

What we have not verified

  1. We have not run Deciphex in our own clinical practice. Pricing, certifications, and EHR-integration claims come from vendor documentation and have not been independently audited.
  2. Enterprise pricing tiers and SLA terms are typically under NDA and not publicly verifiable. Numbers shown reflect publicly disclosed self-service or list pricing only.
  3. Real-world latency, note quality, and accuracy in your specific specialty and patient population can vary materially from vendor demonstrations. We recommend a 30-day trial with two providers before commitment.

Last verified . Read our methodology · Pathology